Metabolic disorders in patients with excessive weights: formation and forecasting

Authors

  • Misyura K. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Kravchun P. Kharkiv National Medical University, Kharkiv, Ukraine
  • Dunayeva I. Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine
  • Kravchun N. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2019.1.05

Keywords:

obesity, metabolic disorders, mathematical model of forecasting

Abstract

According to the results of the complex laboratory-instrumental survey of adult urban population of Kharkiv, a mathematical model has been created that allows estimating the risk of developing metabolic syndrome in patients with excess in terms of anthropometric indices, body composition parameters, carbohydrate and lipid metabolism, clusterin concentration in the blood, and the value of the cardiac index masses of the body of different degrees — representatives of the Ukrainian population. The diagnostic accuracy of the proposed model is quite high: sensitivity — 82.8 %; specificity — 91.45 %; accuracy — 88.07 %; the odds ratio — 40.449. Application of the model in the system of practical health care will improve the risk-stratification of metabolic syndrome, timely conduct therapy to prevent its complications.

References

WHO. Obesity and overweight 2016, available at: www.who.int/mediacentre/factsheets/fs311/en/

Lu Y, Hajifathalian K, Ezzati M, et al. Lancet 2014; 383 (9921): 970-983. doi: http://doi.org/10.1016/S0140–6736 (13)61836-X.

Metodychni rekomendacii' z pryvodu konsul'tuvannja pacijentiv shhodo osnovnyh zasad zdorovogo harchuvannja. Mezhdunar Jendokrinol Zhurn 2013; 5 (53): 138-147.

Lobykina EN. Organizacija profilaktiki i lechenija ozhirenija i izbytochnoj massy tela vzroslogo naselenija krupnogo promyshlennogo centra (na primere Novokuznecka, Kemerovo, 2009: 331 p.

WHO. The challenge of obesity in the WHO European Region and the strategies for response, available at:

http://www.euro.who.int/__data/assets/pdf_file/0008/98243/E89858.pdf.

WHO. Cardiovascular disease, available at: http://www.who.int/cardiovascular_diseases/priorities/en.

WHO. Diabetes Programme, available at: http://www.who.int/diabetes/goal/en.

Oslopov VN, Oslopova JuV. RMZh 2013; 19: 956.

Kir'janov BF, Tokmachjov MS. K34 Matematicheskie modeli v zdravoohranenii : ucheb. рosobie, Velikij Novgorod,2009: 279 p.

Mazurina NV. Ozhirenie i Metabolizm 2009; 2: 7-11.

Ikejima H, Imanishi T, Tsujioka H, et al. Circulation J 2010; 74: 337-345.

Liu H, Jiang D, Zhang S, Ou B. Cardiovascular Drugs Ther 2010; 24: 17-24. doi: http://doi.org/10.1007/s10557-009-6210-7.

White GE, Tan TC, John AE, et al. Cardiovascular Res 2010; 85: 825-835. doi: http://doi.org/10.1093/cvr/cvp341.

Schkfer A, Schulz C, Fraccarollo D, et al. Arterioscler Thromb Vasc Biol 2007; 27 (1): 55-62.

Yoneda O, Imai T. J Immunol 2000; 164 (8): 4055-4062.

Mizutani N, Sakurai T, Shibata T, et al. Immunology 2007; 179: 7478-7487.

Yun Sok Lee, Hidetaka Morinaga, Jane J. Kim, et al.Open Archive. doi: http://dx.doi.org/10.1016/j.cell.2013.03.001.

Arnold T, Brandlhofer S, Vrtikapa K, et al. Pediatr Res 2011; 69: 237-242. doi: http://doi.org/10.1203/PDR.0b013e31820930cb.

Won JC, Park CY, Oh SW, et al. PLoS One 2014; 9 (7):e103351. doi: http://doi.org/10.1371/journal.pone.0103351.

Yan M, Su B, Peng W, et al. J Diabetes Res 2014; 2014:868-732. doi: http://doi.org/10.1155/2014/868732.

Gorshuns'ka MJu. Probl Endokryn Patologii' 2015; 2:15-21.

Wang XH, Dou LZ, Gu C. Trop Med 2014; 7 (1): 55-62.doi: http://doi.org/10.1016/S1995-7645(13)60192-3.

Misjura KV, Kravchun PP. Visn Probl Biologii' i Medycyny 2017; 1 (137): 174-179.

Misjura KV, Kravchun PP. Mizhnar Endokrynol Zhurn 2017; 13 (3): 33-40.

Misjura KV, Kravchun PP. Mizhnar Endokrynol Zhurn 2017; 13 (4): 22-27.

Misjura KV. L'viv Med Chasopys 2017; 3: 20-30.

Misjura KV. Mizhnar Endokrynol Zhurn 2017; 13 (6): 429-434.

Misiura KV. Endokrynologia 2017; 22 (3): 228-236.

Misiura KV. Endokrynologia 2017; 23 (4): 315-325.

Misjura KV, Kravchun PP. Klinichna endokrynologija ta endokrynna hirurgija 2017; 3 (59): 60-68.

Misjura KV. Klinichna endokrynologija ta endokrynna hirurgija 2017; 4 (60): 70-82.

Jubickaja NS, Antonjuk MV, Veremchuk LV. Fundamental'nye issledovanija 2014; 7-3: 66-69.

Gojko OV. Medychna informatyka ta inzhenerija 2009;4: 39-44.

Zavalko AF. Vestnik novyh medicinskih tehnologij 2011; 18 (1): 25-26.

Trushkina IV, Filipov GP, Leont'eva IV. Pediatrija 2010;89 (5): 33-36.

Patent 2403868. Sposob ocenki riska razvitija metabolicheskogo sindroma u bol'nyh hronicheskim holecistitom.

Patent 2321354. Sposob diagnostiki stadij metabolicheskogo sindroma.

Patent 2367950. Sposob prognozirovanija razvitija metabolicheskogo sindroma pri arterial'noj gipertonii u muzhchin.

Patent 2530770. Sposob prognozirovanija riska metabolicheskogo sindroma.

Downloads

Published

2021-07-06

How to Cite

Misyura, K. ., Kravchun, P. ., Dunayeva, I. ., & Kravchun, N. . (2021). Metabolic disorders in patients with excessive weights: formation and forecasting. Problems of Endocrine Pathology, 67(1), 38-51. https://doi.org/10.21856/j-PEP.2019.1.05

Issue

Section

CLINICAL ENDOCRINOLOGY